CRIS Current Research Information System

CUCCHETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.534
AS - Asia 18.796
EU - Europa 13.782
SA - Sud America 1.188
AF - Africa 1.125
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 57.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.238
VN - Vietnam 5.211
SG - Singapore 5.174
CN - Cina 3.976
GB - Regno Unito 3.133
IT - Italia 2.148
DE - Germania 1.924
HK - Hong Kong 1.613
NL - Olanda 1.398
SE - Svezia 1.336
IN - India 1.026
BR - Brasile 861
FR - Francia 859
RU - Federazione Russa 708
IE - Irlanda 527
UA - Ucraina 462
BD - Bangladesh 342
ZA - Sudafrica 315
JP - Giappone 304
CI - Costa d'Avorio 264
KR - Corea 261
FI - Finlandia 247
TG - Togo 243
CH - Svizzera 231
EE - Estonia 227
CA - Canada 156
BG - Bulgaria 137
AR - Argentina 134
PH - Filippine 115
JO - Giordania 109
SC - Seychelles 102
TH - Thailandia 95
AT - Austria 87
ID - Indonesia 84
MX - Messico 80
IQ - Iraq 74
TR - Turchia 72
NG - Nigeria 66
BE - Belgio 61
EC - Ecuador 61
PK - Pakistan 57
ES - Italia 51
PL - Polonia 50
SA - Arabia Saudita 44
TW - Taiwan 36
CL - Cile 31
UZ - Uzbekistan 31
HR - Croazia 29
CO - Colombia 27
GR - Grecia 27
IR - Iran 27
MA - Marocco 27
AU - Australia 26
MY - Malesia 25
EG - Egitto 22
PE - Perù 21
RO - Romania 19
VE - Venezuela 19
LT - Lituania 18
PY - Paraguay 18
ET - Etiopia 17
LB - Libano 17
CZ - Repubblica Ceca 16
NP - Nepal 15
DZ - Algeria 14
JM - Giamaica 13
KE - Kenya 13
PT - Portogallo 12
HU - Ungheria 11
TN - Tunisia 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
MO - Macao, regione amministrativa speciale della Cina 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
NO - Norvegia 7
SK - Slovacchia (Repubblica Slovacca) 7
IL - Israele 6
OM - Oman 6
RS - Serbia 6
AL - Albania 5
KH - Cambogia 5
MD - Moldavia 5
MK - Macedonia 5
PS - Palestinian Territory 5
BO - Bolivia 4
GH - Ghana 4
HN - Honduras 4
LU - Lussemburgo 4
MM - Myanmar 4
SI - Slovenia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
Totale 57.376
Salva come PNG Salva come JPEG
Città #
Singapore 3.593
Fairfield 2.941
Southend 2.754
Ashburn 2.267
Hong Kong 1.510
Chandler 1.319
Woodbridge 1.210
Dong Ket 1.105
Ho Chi Minh City 1.087
San Jose 1.009
Seattle 1.008
Wilmington 1.006
Houston 977
Hanoi 832
Cambridge 821
Santa Clara 768
Princeton 683
Kerkrade 651
Beijing 534
Ann Arbor 529
Dublin 525
Bologna 492
Boardman 483
Frankfurt am Main 455
Los Angeles 428
Hefei 418
Lauterbourg 361
Eygelshoven 338
New York 310
Westminster 276
Nanjing 268
Abidjan 264
Dallas 260
Tokyo 256
Jacksonville 246
Lomé 243
Padova 228
Council Bluffs 218
Berlin 204
Seoul 193
Helsinki 184
Bern 174
Buffalo 172
Da Nang 170
San Diego 142
Milan 141
Jinan 138
São Paulo 133
Sofia 132
Haiphong 131
Shenyang 131
Saint Petersburg 130
Redondo Beach 129
Florence 125
Munich 121
Amman 105
Guangzhou 101
Shanghai 94
Delhi 92
Redmond 90
Chicago 89
Changsha 87
Turin 86
Nanchang 85
Dearborn 83
Hebei 71
The Dalles 71
Hải Dương 69
Des Moines 67
Rome 67
Hangzhou 60
London 60
Falls Church 58
Phoenix 58
Biên Hòa 57
Brussels 57
Jiaxing 57
Tianjin 57
Zhengzhou 57
Abeokuta 55
Johannesburg 54
Medford 53
Mülheim 52
Bengaluru 50
Norwalk 50
Orem 50
Toronto 50
Amsterdam 48
Atlanta 45
Vienna 45
Falkenstein 44
San Francisco 42
Montreal 41
Olalla 40
Turku 40
Brooklyn 39
Jakarta 39
Nuremberg 39
Wuhan 38
Can Tho 36
Totale 37.951
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.635
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 501
A comprehensive analysis on expected years of life lost due to pancreatic cancer 310
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 302
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 288
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 268
A new liver transplant priority for patients with hepatocellular carcinoma. 266
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 265
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 261
Burnout and psychological distress between surgical and non-surgical residents 257
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 255
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 249
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 247
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 244
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 244
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation 242
Pattern of macrovascular invasion in hepatocellular carcinoma 242
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 236
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 235
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 233
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 228
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 224
Bacterial translocation in adult small bowel transplantation 223
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 223
Abdominal wall transplantation with microsurgical technique 223
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 219
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 219
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 218
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 218
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 218
Combined liver–dual kidney transplant: Role in expanded donors 216
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 215
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 215
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 215
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 215
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 215
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 214
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 212
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 212
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 212
Coping strategies in intestinal transplantation 211
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 210
The changing scenario of hepatocellular carcinoma in Italy: an update 209
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 208
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 208
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 207
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 206
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 206
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 205
Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation. 205
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 205
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 204
Pancreas: Comic Biography of an Organ 204
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 203
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 203
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 203
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 202
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 200
Metabolic disorders across hepatocellular carcinoma in Italy 200
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 200
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 198
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 197
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 196
Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma. 196
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 196
In Reply 195
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 195
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 192
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 192
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 190
Analysis of cardiovascular, acid-base status, electrolyte and coagulation changes during small bowel transplantation 189
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 189
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 188
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 188
Impact of preoperative infection on outcome after liver transplantation 188
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 187
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 187
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma 184
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis 184
Post-reperfusion syndrome during isolated intestinal transplantation: outcome and predictors 183
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 183
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 183
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma 183
Assessment of long-term prognosis at detection of early hepatocellular carcinoma remains unsolved 182
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 182
Age and equity in liver transplantation: An organ allocation model. 181
Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levels 181
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? 181
The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study 181
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 180
Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 180
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation 178
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 178
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 177
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 176
Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: A systematic review and meta-analysis 175
Efficacy and Cost-Effectiveness of Immediate Surgery versus a Wait-and-See Strategy for Sporadic Nonfunctioning T1 Pancreatic Endocrine Neoplasms. 174
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 172
Totale 22.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.778 0 0 0 0 0 0 0 0 0 0 0 1.778
2021/20226.222 472 228 353 386 575 297 149 441 259 295 1.855 912
2022/20236.206 633 959 330 736 395 483 212 349 1.106 160 493 350
2023/20241.784 132 303 137 165 154 361 76 108 100 124 63 61
2024/20257.588 351 1.170 671 604 1.151 408 463 208 127 535 333 1.567
2025/202620.732 1.536 1.352 1.639 1.282 1.952 2.244 3.155 612 3.727 1.615 853 765
Totale 58.521